usual
diffus
natur
term
uri
come
encompass
multipl
clinic
entiti
includ
pharyng
sinus
bronchiti
well
nonspecif
respiratori
infect
design
includ
common
cold
classif
scheme
base
upon
predomin
anatom
site
present
symptom
complex
tend
poorli
specif
direct
therapi
diagnos
treatment
examin
rel
nonspecif
uri
determin
evidencebas
indic
rel
valu
antibiot
therapi
may
limit
unnecessari
use
although
thorough
examin
viral
uri
beyond
scope
articl
brief
review
nonspecif
undifferenti
uri
treatment
may
provid
context
discuss
specif
condit
inappropri
use
antibiot
respiratori
infect
particular
implic
emerg
antibiot
resist
especi
streptococcu
pneumonia
guidelin
diagnosi
treatment
uri
base
upon
nonfoc
present
develop
effort
limit
indiscrimin
use
antibiot
gener
viral
ill
cours
viral
uri
also
term
acut
rhinopharyng
gener
selflimit
natur
mild
sever
symptom
may
persist
greater
week
durat
case
persist
week
caus
commonli
rhinoviru
lesser
extent
coronaviru
typic
midwint
adenoviru
typic
spring
fall
although
laboratori
identif
accomplish
time
requir
identifi
caus
may
exceed
durat
ill
yield
may
highli
variabl
syndrom
involv
symptom
greater
sever
commonli
includ
lower
respiratori
tract
caus
influenza
parainfluenza
respiratori
synciti
viru
may
benefit
prompt
identif
influenza
initi
time
neuraminidas
inhibitor
therapi
appear
howev
neither
rapid
influenza
test
clinic
predict
rule
superior
clinic
judgment
establish
diagnosi
treatment
uri
essenti
symptomdirect
antibiot
treatment
appear
contribut
resolut
ill
benefit
prevent
lifethreaten
complic
mening
sepsi
abscess
patient
adequ
assess
bacteri
sinus
may
develop
complic
minor
patient
review
later
improv
expect
uri
first
week
notwithstand
report
sinu
chang
may
demonstr
ct
studi
patient
first
day
ill
recent
systemat
review
literatur
found
insuffici
evid
warrant
use
antibiot
uri
adult
children
adult
experienc
greater
rate
advers
effect
antibiot
placebo
patient
respiratori
infect
may
certain
expect
antibiot
prescript
physician
may
prescrib
antibiot
base
percept
expect
howev
patient
satisfact
correl
physician
time
spent
patient
understand
diagnosi
greater
extent
prescript
antibiot
patient
upper
respiratori
symptom
random
receiv
immedi
antibiot
antibiot
use
delay
hour
clinic
outcom
significantli
differ
symptom
although
symptom
score
worsen
delay
use
group
sore
throat
otiti
media
signific
variabl
symptom
score
note
trial
clinic
decis
support
system
guid
physician
appropri
antibiot
use
respiratori
infect
may
reduc
inappropri
use
use
oral
topic
nasal
decongest
provid
benefit
shortterm
use
adult
evid
support
use
children
studi
treatment
antihistamin
alon
common
cold
shown
faster
recoveri
small
benefit
sneez
rhinorrhea
expens
sedat
combin
decongest
effect
seen
small
children
benefit
gener
recoveri
nasal
symptom
note
older
children
adult
intranas
ipratropium
decreas
rhinorrhea
may
decreas
sneez
promot
nasal
dri
evid
use
zinc
treatment
uri
inconclus
echinacea
extract
show
signific
effect
either
infect
rate
rhinoviru
symptom
sever
role
vitamin
c
prevent
appear
limit
perhap
individu
expos
sever
physic
lowtemperatur
stress
therapeut
benefit
limit
equivoc
pharynx
common
portal
human
respiratori
digest
tract
expos
multipl
potenti
pathogen
pharyng
predominantli
viral
etiolog
account
much
case
adult
cardin
featur
sore
throat
also
featur
common
cold
adenoviru
infect
usual
accompani
aden
conjunct
associ
eros
stomatopharyng
herp
simplex
coxsacki
viru
infect
sore
throat
associ
pharyng
vesicl
herpangina
hand
foot
vesicl
epsteinbarr
viru
infect
character
fatigu
function
impair
cervic
lymphadenopathi
mononucleosi
bacteri
caus
sore
throat
includ
group
bhemolyt
streptococcu
gabh
common
caus
bacteri
pharyng
nongroupa
streptococcu
less
common
caus
mycoplasma
pneumonia
chlamydia
pneumonia
neisseria
gonorrhoea
rare
caus
arcanobacterium
haemolyticum
associ
exanthema
may
mimic
rash
scarlet
fever
among
variou
caus
commonli
occur
infect
antibiot
therapi
benefici
gabh
goal
treat
gabh
includ
expedit
clinic
recoveri
decreas
likelihood
suppur
complic
abscess
prevent
acut
rheumat
fever
limit
transmiss
diseas
time
exclud
treatment
patient
pharyng
infect
gabh
advers
effect
treatment
emerg
antibioticresist
bacteria
avoid
gabh
may
account
pharyng
adult
school
age
children
yet
nation
survey
adult
children
pharyng
treat
antibiot
typic
symptom
streptococc
pharyng
sudden
onset
sore
throat
accompani
fever
children
abdomin
pain
vomit
also
report
presenc
cough
rhinorrhea
suggest
nongabh
etiolog
physic
find
may
includ
pharyng
erythema
tonsillar
exud
enlarg
cervic
lymph
node
fever
palat
petechia
uvular
swell
none
specif
streptococc
infect
also
found
histor
physic
featur
common
infect
agent
includ
group
c
group
g
streptococcu
physician
may
unabl
clinic
distinguish
gabh
caus
pharyng
antibiot
withheld
laboratori
test
case
necessari
confirm
diagnosi
throat
cultur
consist
throat
swab
incub
blood
agar
confirm
gabh
growth
inhibitori
effect
bacitracin
standard
diagnosi
howev
result
cultur
avail
hour
delay
immedi
appropri
therapi
delay
benefit
time
treatment
includ
reduc
risk
diseas
transmiss
diminish
symptom
speed
recoveri
jeopard
rapid
antigen
detect
test
radt
gabh
develop
provid
immedi
albeit
costli
result
demonstr
specif
exceed
rel
blood
agar
cultur
clinic
score
base
cumul
presenc
absenc
specif
clinic
featur
may
use
exclud
entertain
diagnosi
gabh
therebi
reduc
need
throat
cultur
unnecessari
antibiot
use
sore
throat
score
determin
treatment
children
adult
universitybas
famili
practic
demonstr
reduct
antibiot
prescript
compar
usual
care
communitybas
famili
practic
mcisaac
colleagu
assess
clinic
score
valid
result
reduct
antibiot
prescript
reduct
throat
cultur
sensit
specif
score
rel
cultur
respect
tabl
systemat
review
clinic
diagnosi
strep
throat
ebel
cowork
show
presenc
tonsillar
pharyng
exud
exposur
strep
throat
infect
previou
week
reliabl
predict
likelihood
gabh
pharyng
posit
likelihood
ratio
lr
respect
absenc
tender
anterior
cervic
node
tonsillar
enlarg
exud
reliabl
predictor
gabh
present
neg
lr
respect
singl
element
histori
physic
examin
alon
suffici
exclud
diagnos
strep
throat
base
preval
gabh
given
popul
clinic
predict
rule
use
calcul
individu
probabl
gabh
pharyng
tabl
american
colleg
physician
acp
develop
guidelin
diagnosi
pharyng
adult
base
upon
clinic
predict
rule
throat
cultur
exclud
diagnost
algorithm
delay
result
preclud
immedi
treatment
decis
potenti
benefit
symptom
relief
addit
concern
failur
cultur
discrimin
infect
carrier
state
instead
recommend
assess
radt
patient
two
three
clinic
criteria
intermedi
risk
treat
posit
test
patient
three
four
criteria
treat
empir
other
neither
test
treat
approach
acknowledg
chanc
undertreat
base
test
design
intermedi
high
risk
criteria
sensit
specif
approxim
emphas
rel
low
likelihood
suppur
complic
acut
rheumat
fever
costeffect
analysi
compar
five
strategi
diagnosi
manag
pharyng
adult
assum
gabh
preval
decis
model
construct
evalu
strategi
observ
empir
therapi
twoplat
throat
cultur
radt
optic
immunoassay
follow
cultur
confirm
neg
result
radt
alon
find
analysi
gener
support
acp
guidelin
except
margin
superior
cost
effect
seen
cultur
strategi
differ
littl
costeffect
howev
empir
therapi
achiev
reason
costeffect
high
gabh
preval
assum
guidelin
provid
infecti
diseas
societi
america
diagnosi
manag
gabh
pharyng
call
laboratori
test
base
epidemiolog
clinic
featur
exclus
appear
low
risk
confirmatori
cultur
neg
radt
result
adult
recommend
confirmatori
throat
cultur
advis
radt
neg
children
adolesc
higher
preval
gabh
acut
rheumat
fever
followup
cultur
recommend
appropri
therapi
asymptomat
individu
except
circumst
epidem
close
commun
recurr
infect
household
carriag
suspect
treatment
gabh
aim
erad
organ
upper
respiratori
tract
cochran
review
assess
benefit
antibiot
treatment
sore
throat
studi
demonstr
reduct
rheumat
fever
antibiot
therapi
found
benefit
modest
larg
number
individu
need
treat
deriv
meaning
benefit
reduct
symptom
sore
throat
headach
fever
one
half
seen
antibiot
therapi
day
ill
five
patient
would
need
treat
antibiot
elimin
one
sore
throat
day
seven
patient
would
need
treat
elimin
one
sore
throat
day
subgroup
analysi
patient
evalu
throat
swab
streptococcu
reveal
significantli
greater
symptom
reduct
antibiot
treatment
posit
swab
neg
swab
antibiot
therapi
result
reduct
incid
suppur
complic
includ
otiti
media
sinus
quinsi
peritonsillar
abscess
compar
placebo
penicillin
recommend
treatment
gabh
pharyng
penicillinallerg
patient
erythromycin
recommend
gabh
resist
penicillin
report
howev
resist
macrolid
includ
erythromycin
seen
firstgener
cephalosporin
accept
altern
patient
histori
nonanaphylact
allergi
blactam
antibiot
although
cours
penicillin
recommend
erad
gabh
shorter
cours
therapi
agent
shown
effect
provid
written
instruct
use
antibiot
sore
throat
improv
complianc
treatment
pharyng
corticosteroid
demonstr
inconsist
result
one
studi
singl
dose
oral
dexamethason
mgkg
provid
greater
pain
relief
placebo
children
moder
sever
pharyng
caus
gabh
nongabh
somewhat
smaller
studi
similar
design
antigenposit
subset
children
report
improv
time
onset
pain
relief
dexamethason
treatment
compar
placebo
signific
decreas
time
onset
pain
relief
time
complet
pain
relief
seen
antigenneg
treatment
group
compar
placebo
inflamm
mucosa
paranas
sinus
sinus
among
group
respiratori
ill
exclud
pharyng
rank
second
frequenc
visit
outpati
clinic
term
rhinosinus
may
accur
describ
condit
inflamm
nasal
mucosa
usual
present
well
although
usual
caus
viral
infect
rhinosinus
often
attribut
patient
physician
bacteri
caus
noninfecti
caus
sinus
includ
allergi
foreign
bodi
deviat
septum
tumor
polyp
barotrauma
although
bacteri
sinus
may
complic
uri
account
disproportion
antibiot
prescript
written
acut
bacteri
rhinosinus
abr
share
symptom
viral
uri
includ
rhinorrhea
nasal
congest
facial
pressur
fever
may
lead
patient
request
antibiot
physician
though
antibiot
therapi
may
benefici
bacteri
sinus
definit
diagnosi
made
sinu
aspir
invas
procedur
typic
perform
offic
set
instead
physician
must
reli
present
persist
symptom
complex
includ
facial
pressur
nasal
obstruct
nasal
discharg
hyposmia
fever
treatment
guidelin
sinus
gener
direct
reduc
inappropri
use
antibiot
viral
respiratori
infect
articl
address
evalu
therapi
abr
immunocompet
adult
children
age
year
older
paranas
sinus
typic
involv
abr
maxillari
ethmoid
sinus
sinus
present
birth
form
third
fourth
gestat
month
sphenoid
sinu
develop
earli
childhood
frontal
sinus
develop
adolesc
infect
frontal
sinus
typic
present
greater
intens
sever
may
requir
hospit
admiss
bacteri
infect
typic
follow
impair
mucu
clearanc
obstruct
sinu
ostia
caus
viral
respiratori
infect
paranas
sinus
ordinarili
steril
infect
common
microorgan
isol
maxillari
sinus
pneumonia
haemophilu
influenza
moraxella
catarrhali
sinus
defin
acut
symptom
durat
less
week
chronic
symptom
persist
week
complic
potenti
quit
seriou
anatom
relationship
sinus
eye
brain
complic
includ
orbit
cellul
orbit
abscess
potenti
lifethreaten
intracrani
complic
cavern
sinu
thrombosi
mening
brain
abscess
chronic
sinus
defin
presenc
two
major
one
major
two
minor
criteria
criteria
list
box
noninfecti
factor
allergi
irrit
appear
initi
caus
inflamm
bacteria
may
role
persist
antibiot
therapi
chronic
rhinosinus
shown
improv
outcom
children
wherea
benefit
antibiot
therapi
adult
chronic
sinus
studi
endoscop
surgeri
may
use
treatment
chronic
rhinosinus
fail
resolv
conserv
therapi
diagnosi
abr
complic
symptom
share
viral
uri
lack
data
correl
symptom
sinu
aspir
find
clinic
impress
alon
may
result
accuraci
diagnosi
primari
care
physician
current
guidelin
provid
diagnosi
abr
patient
durat
ill
typic
symptom
day
patient
rhinoviru
infect
may
symptom
one
day
well
day
resolut
symptom
day
evalu
patient
symptom
physic
featur
rel
radiolog
find
studi
featur
associ
signific
ct
find
airfluid
level
complet
sinu
opacif
includ
purul
rhinorrhea
erythrocyt
sediment
rate
greater
purul
nasal
secret
doubl
sicken
symptom
worsen
initi
resolut
ct
find
howev
specif
abr
seen
patient
uri
william
colleagu
use
sinu
radiograph
chang
identifi
five
predictor
abr
name
maxillari
toothach
poor
respons
decongest
histori
discolor
nasal
discharg
mucopurul
nasal
discharg
examin
abnorm
transillumin
singl
find
suffici
specif
sensit
diagnost
although
transillumin
sinus
found
independ
predictor
sinus
util
limit
maxillari
frontal
sinus
difficult
perform
like
unreli
younger
children
practic
use
appear
limit
hansen
cowork
found
relationship
posit
bacteri
cultur
sinu
aspir
unilater
tender
maxillari
sinu
maxillari
pain
maxillari
toothach
mucopurul
nasal
discharg
studi
emerg
room
patient
symptom
sinus
day
found
increas
likelihood
abr
purul
sinu
aspir
cultur
unilater
predomin
purul
nasal
discharg
unilater
predomin
facial
pain
histori
bilater
purul
nasal
discharg
pu
nasal
caviti
review
studi
identifi
clinic
sign
symptom
abr
appear
purul
nasal
discharg
unilater
maxillari
tender
worsen
symptom
initi
improv
predict
higher
likelihood
diagnosi
radiographi
employ
evalu
abr
signific
limit
abil
reliabl
predict
diagnosi
particular
mucos
thicken
lack
specif
find
abr
predict
clinic
judgment
patient
either
complet
sinu
opacif
air
fluid
level
benefit
treatment
abr
amoxicillin
find
rel
high
specif
approxim
respect
sensit
radiograph
neg
three
find
normal
studi
power
evid
exclud
abr
manag
guidelin
exclud
radiographi
routin
evalu
sinus
children
adult
ct
abil
visual
paranas
sinus
osteomeat
complex
anatom
entiti
central
diagnosi
abr
lindbaek
colleagu
found
differ
outcom
patient
clinic
diagnosi
sinus
mucos
thicken
ct
treat
either
amoxicillin
placebo
patient
undergo
ct
examin
reason
sinus
histori
recent
uri
found
sinu
abnorm
chang
seen
ct
examin
suffici
specif
sinus
ct
use
care
within
clinic
context
surgic
manag
consid
case
persist
infect
complic
infect
ct
may
indic
plan
therapi
ration
approach
treatment
abr
somewhat
limit
diagnost
uncertainti
describ
nevertheless
guidelin
publish
advoc
antibiot
therapi
dictat
sever
durat
symptom
antibiot
therapi
shown
shorten
durat
symptom
patient
purul
rhinorrhea
compar
placebo
howev
differ
overal
recoveri
seen
antibiot
group
higher
frequenc
diarrhea
studi
particip
limit
pu
nasal
caviti
facial
pressur
nasal
discharg
last
longer
day
group
treat
antibiot
experienc
symptom
improv
earlier
versu
day
signific
differ
improv
day
cochran
review
antibiot
therapi
persist
day
nasal
discharg
children
found
reduct
probabl
persist
symptom
short
medium
term
eight
children
need
treat
achiev
one
addit
cure
systemat
review
antibiot
therapi
acut
maxillari
sinus
adult
includ
studi
signific
variabl
among
compar
antibiot
control
antibiot
differ
class
penicillin
improv
clinic
cure
radiograph
outcom
signific
differ
seen
class
antibiot
recommend
american
colleg
physiciansamerican
societi
intern
medicin
acpsim
symptomat
treatment
reassur
mild
moder
symptom
antibiot
reserv
sever
persist
symptom
day
surmis
modest
improv
seen
studi
use
rel
nonspecif
standard
clinic
radiograph
caus
inclus
patient
bacteri
infect
agent
narrowest
spectrum
activ
like
pathogen
recommend
amoxicillin
prefer
american
academi
otolaryngologyhead
neck
surgeri
recommend
initi
therapi
adult
mild
diseas
receiv
antibiot
previou
week
firstlin
agent
amoxicillin
mild
diseas
antibiot
use
previou
week
moder
diseas
treat
secondlin
agent
includ
fluoroquinolon
failur
respond
hour
therapi
prompt
reevalu
therapi
likewis
treatment
children
sever
diseas
prior
treatment
antibiot
determin
therapi
choic
exclud
fluoroquinolon
efficaci
predict
accord
mathemat
model
base
expect
pathogen
spontan
resolut
rate
vitro
activ
american
academi
pediatr
recommend
antibiot
therapi
children
sinus
meet
clinic
definit
whose
symptom
sever
persist
amoxicillin
recommend
usual
dose
mgkg
two
divid
dose
children
mild
moder
diseas
attend
day
care
recent
treat
antibiot
failur
improv
reduct
respiratori
symptom
gener
wellb
within
hour
lead
reconsider
diagnosi
chang
therapi
highdos
amoxicillin
mgkg
advis
patient
fail
improv
usual
dose
amoxicillin
moder
sever
ill
recent
treat
antibiot
attend
day
care
altern
blactam
allerg
patient
includ
cefdinir
cefuroxim
cefpodoxim
clarithromycin
azithromycin
recommend
anaphylaxistyp
blactam
allerg
patient
data
concern
use
addit
nonantimicrobi
therapi
sinus
cours
prednison
mgkg
combin
cefpodoxim
result
less
pain
nasal
obstruct
first
day
compar
placebo
adult
radiographor
endoscopedocu
maxillari
rhinosinus
daili
hyperton
salin
use
month
patient
histori
sinus
result
improv
symptom
sever
sinusitisrel
disabl
score
less
antibiot
use
addit
intranas
steroid
antibiot
therapi
acut
rhinosinus
patient
histori
chronic
recurr
sinu
symptom
achiev
higher
rapid
rate
patientreport
clinic
success
placebo
unlik
diagnost
entiti
review
acut
bronchiti
refer
inflamm
portion
lower
respiratori
tract
like
pharyng
sinus
howev
condit
share
primari
symptom
case
cough
nonspecif
uri
ill
viral
origin
requir
antibiot
therapi
specif
condit
evid
benefit
antibiot
therapi
minor
case
relationship
viral
uri
acut
bronchiti
defin
acut
cough
ill
otherwis
healthi
adult
includ
review
acut
bronchiti
gener
refer
infect
respiratori
tract
cough
predomin
featur
survey
definit
acut
bronchiti
disagr
among
famili
physician
qualifi
cough
purul
other
indic
must
product
although
systemat
review
found
antibiot
therapi
acut
bronchiti
offer
modest
benefit
report
offic
visit
diagnosi
result
prescript
antibiot
treatment
guidelin
develop
effort
limit
unnecessari
antibiot
therapi
condit
major
case
acut
bronchiti
caus
infect
virus
includ
influenza
parainfluenza
respiratori
syncyti
viru
result
lower
tract
diseas
rhinoviru
coronaviru
adenoviru
usual
result
upper
tract
diseas
etiolog
studi
adult
lower
respiratori
tract
infect
control
identifi
rhinoviru
influenza
patient
noninfecti
caus
acut
cough
includ
allergi
asthma
environment
exposur
heart
failur
gastroesophag
reflux
tumor
coughvari
asthma
may
difficult
distinguish
uncompl
acut
bronchiti
may
also
associ
transient
bronchial
hyperrespons
typic
resolv
week
caus
identifi
uniqu
epidemiolog
clinic
featur
tabl
bacteri
infect
caus
fewer
case
infecti
bronchiti
bordetella
pertussi
pneumonia
c
pneumonia
identifi
primari
agent
pneumonia
rel
frequent
import
caus
cough
must
exclud
diagnosi
may
associ
signific
mortal
cough
acut
bronchiti
may
product
may
accompani
wheez
reflect
hypersensit
bronchial
epithelium
measur
pulmonari
function
test
abnorm
promin
week
infect
abnorm
typic
persist
week
may
last
longer
studi
patient
present
gener
medic
practic
acut
cough
purul
sputum
abnorm
auscultori
find
week
patient
well
abl
resum
usual
activ
although
product
cough
particular
purul
sputum
associ
antibiot
use
physician
featur
nonspecif
sign
inflamm
predict
bacteri
infect
establish
criteria
diagnosi
pneumonia
includ
purul
sputum
patient
present
purul
sputum
pneumonia
rule
exclud
diagnosi
pneumonia
without
need
evalu
base
absenc
abnorm
vital
sign
tachycardia
tachypnea
fever
absenc
specif
adventiti
breath
sound
consolid
sign
rale
egophoni
fremitu
although
may
guid
physician
decis
proceed
radiographi
factor
may
influenc
decis
includ
age
comorbid
patient
likelihood
season
ill
influenza
use
creactiv
protein
measur
distinguish
bacteri
pneumonia
uncompl
acut
bronchiti
studi
appear
offer
advantag
evalu
patient
acut
cough
infect
b
pertussi
consid
histori
exposur
individu
confirm
pertussi
cough
persist
nasopharyng
swab
polymeras
chain
reaction
test
particularli
use
diagnosi
previous
vaccin
individu
less
frequent
meet
clinic
criteria
diseas
increas
report
pertussi
appear
due
wane
vaccin
immun
adolesc
young
adult
use
serolog
diagnosi
pertussi
diagnosi
infect
pneumonia
c
pneumonia
limit
part
seroconvers
may
occur
asymptomat
individu
sputum
cultur
poorli
sensit
speci
recommend
pneumonia
infect
commonli
produc
influenzalik
tracheobronch
selflimit
cours
resolv
week
without
treatment
may
also
produc
atyp
pneumonia
c
pneumonia
infect
respiratori
tract
usual
asymptomat
may
associ
bronchiti
pneumonia
specul
c
pneumonia
may
implic
adult
newonset
asthma
base
serolog
find
patient
therapi
treatment
guidelin
deriv
avail
evid
recommend
routin
antibiot
therapi
uncompl
acut
bronchiti
systemat
review
fail
discov
margin
benefit
treatment
antibiot
acut
bronchiti
patient
includ
smoker
although
shorter
durat
cough
day
product
cough
day
feel
ill
day
note
treat
group
one
review
differ
followup
night
cough
product
cough
activ
limit
anoth
systemat
review
significantli
side
effect
antibiot
treatment
group
trial
specif
examin
antibiot
treatment
smoker
acut
bronchiti
review
exist
data
found
less
benefit
smoker
compar
nonsmok
trial
azithromycin
vitamin
c
therapi
adult
acut
bronchiti
signific
differ
healthrel
qualiti
life
day
antibiot
therapi
recommend
acut
bronchiti
caus
pertussi
cochran
review
antibiot
pertussi
found
shortterm
therapi
azithromycin
day
clarithromycin
day
erythromycin
day
effect
longterm
therapi
erythromycin
erad
infect
nasopharynx
fewer
side
effect
shortterm
treatment
although
clinic
cours
ill
alter
treatment
recommend
individu
bronchiti
expos
document
pertussi
order
decreas
spread
diseas
although
scant
evid
support
use
antibiot
acut
bronchiti
evid
use
chronic
bronchiti
exacerb
mix
us
food
drug
administr
fda
longer
consid
antibiot
trial
acut
bronchiti
warrant
lack
evid
benefit
nevertheless
mani
antibiot
indic
chronic
bronchiti
use
physician
treatment
acut
bronchiti
perhap
due
part
failur
distinguish
otherwis
healthi
patient
acut
selflimit
cough
patient
worsen
symptom
associ
irrevers
lung
diseas
variou
agent
use
provid
symptom
relief
patient
acut
bronchiti
studi
bronchial
hyperrespons
bronchospasm
featur
diseas
signific
percentag
patient
surpris
evid
support
use
bronchodil
individu
demonstr
airflow
obstruct
cough
score
chang
treatment
children
airway
obstruct
studi
adult
differ
cough
day
treatment
control
group
howev
subgroup
airflow
limit
lower
cough
score
wheez
baselin
quicker
resolut
cough
littl
evid
support
use
antituss
specif
acut
bronchiti
guidelin
suggest
may
modest
respons
dextromethorphan
codein
prepar
studi
evalu
efficaci
guaifenesin
expector
although
use
widespread
found
inhibit
capsaicininduc
cough
patient
uri
herbal
agent
pelargonium
sidoid
ep
studi
placebo
adult
acut
bronchiti
less
day
cough
signific
decreas
symptom
sever
score
work
disabl
found
treatment
group
differ
advers
effect
approach
patient
acut
cough
first
identifi
base
histori
physic
examin
individu
like
pneumonia
requir
evalu
specif
therapi
strength
recommend
sor
remain
patient
subset
treatment
antivir
therapi
influenza
may
indic
base
upon
clinic
judgment
season
preval
known
exposur
pertussi
macrolid
therapi
consid
antibiot
therapi
otherwis
indic
unlik
provid
benefit
patient
symptomat
therapi
includ
inhaledbronchodil
show
evid
airway
obstruct
antituss
chest
discomfort
sleep
disturb
cough
may
ad
tabl
evidencebas
recommend
treatment
uri
antibiot
indic
treatment
nonspecif
uri
adult
children
delay
antibiot
therapi
may
decreas
use
effect
outcom
except
symptom
score
otiti
media
pharyng
oral
topic
decongest
benefici
adult
uri
decongestantantihistamin
combin
improv
recoveri
nasal
symptom
older
children
adult
uri
radt
gabh
recommend
pretest
likelihood
intermedi
high
cultur
gabh
recommend
confirm
neg
radt
children
adolesc
c
penicillin
recommend
therapi
gabh
allergi
histori
oral
dexamethason
recommend
speed
pain
relief
pharyng
b
antibiot
therapi
improv
outcom
children
chronic
sinus
radiograph
recommend
routin
evalu
acut
sinus
children
adult
antibiot
recommend
persist
sever
symptom
acut
sinus
combin
prednison
antibiot
decreas
symptom
acut
sinus
antibiot
therapi
indic
acut
bronchiti
unless
symptom
persist
pertussi
exposur
bronchodil
therapi
recommend
bronchiti
evid
airway
obstruct
antituss
therapi
may
improv
cough
bronchiti
c
patient
educ
appropri
antibiot
use
decreas
use
antibiot
uri
patient
educ
physician
appropri
treatment
acut
bronchiti
result
lower
antibiot
usag
without
affect
clinic
outcom
effort
may
includ
provid
inform
leaflet
visit
review
patient
follow
high
likelihood
ill
resolv
without
antibiot
inappropri
antibiot
use
associ
emerg
antibioticresist
bacteria
antibiot
use
associ
risk
advers
event
includ
seriou
allerg
reaction
avoid
term
bronchiti
engend
fear
valu
specifi
treatment
patient
present
primari
care
physician
infect
upper
respiratori
tract
like
experienc
frequent
usual
selflimit
viral
infect
viral
uri
character
nonspecif
symptom
includ
sore
throat
nasal
congest
cough
may
respond
symptomtarget
measur
pharyng
featur
typic
streptococc
infect
rapid
inoffic
test
may
guid
antibiot
treatment
limit
unwarr
use
appropri
treatment
acut
sinus
dictat
assess
histor
physic
featur
gener
requir
diagnost
imag
cough
predomin
symptom
immunocompet
individu
pneumonia
exclud
treatment
antibiot
indic
physician
respons
judici
use
antibiot
may
reduc
emerg
bacteri
resist
also
decreas
advers
reaction
patient
educ
may
mitig
demand
unnecessari
therapi
preserv
satisfact
care
tabl
summar
evidencebas
recommend
treatment
uri
